Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-26 @ 3:46 AM
Study NCT ID:
NCT01924260
Status:
COMPLETED
Last Update Posted:
2022-08-02
First Post:
2013-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer
Sponsor:
Edward Kim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-08
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-13
First Submit QC Date:
None
Study First Post Date:
2013-08-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-28
Last Update Post Date:
2022-08-02
Last Update Post Date Type:
ACTUAL